ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 141K)  | Related Articles | Citation Tracking

Original Article: Treatment
Flexible, intensive insulin therapy and dietary freedom in adolescents and young adults with Type 1 diabetes: a prospective implementation study
A. Sämann*, T. Lehmann, C. Kloos*, A. Braun, W. Hunger-Dathe*, G. Wolf* and U. A. Müller*
  *Department of Internal Medicine III, Friedrich-Schiller-University, Jena, Germany,   IHK Thuringia, Erfurt, Germany and   Bethanien Hospital, Heidelberg, Germany
Correspondence to: Alexander Sämann, Klinik für Innere Medizin III, Erlanger Allee 101, Friedrich-Schiller-Universität, 07740 Jena, Germany. E-mail: alexander.saemann@med.uni-jena.de
Copyright Journal compilation © 2008 Diabetes UK
KEYWORDS
adolescents • Type 1 diabetes • severe hypoglycaemia • severe ketoacidosis • patient education

Diabet. Med. 25, 592–596 (2008)

ABSTRACT

AbstractIntroductionSubjects and methodsResultsDiscussionReferences

Aims  To assess the outcome of a Diabetes Treatment and Teaching Programme (DTTP) on glycated haemoglobin (HbA1c), severe hypoglycaemia (SH) and severe ketoacidosis (SKA) in adolescents and young adults with Type 1 diabetes.

Methods  Quality-assurance project with assessment of participants 1 year after participation in a DTTP (5-day inpatient course, groups ≤ 10 patients, fixed curriculum of education/training, introduction of dietary freedom). Before–after analyses of participants aged 12–15, 15–18, 18–21 and 21–24 years. Main outcome measures were HbA1c, SH and SKA.

Results  For the 1592 participants, aged 12 to 24 years, mean age at enrolment was 19 ± 3 years, mean duration of diabetes was 7.3 ± 5.4 (range 0.3–24) years, mean baseline HbA1c declined from 8.8 ± 2.3% to 8.1 ± 2.0%. The incidence of SH was 0.31 vs. 0.11 events/patient/year; the incidence of SKA 0.17 vs. 0.07 events/patient/year. In mixed effects models taking into account effects of centres, age and diabetes duration, the mean difference was −0.64%[P < 0.001, 95% confidence interval (CI) −0.79 to −0.5] for HbA1c, −0.2 events/patient/year (P < 0.0001, 95% CI −0.28 to −0.12) for SH and −0.1 events/patient/year (P < 0.0001, 95% CI −0.14 to −0.06) for SKA.

Conclusions  Adolescents and young adults with Type 1 diabetes benefit from participation in a standard DTTP for flexible, intensive insulin therapy and dietary freedom.


Accepted 21 November 2007

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1464-5491.2008.02406.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member